In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by Biotechna SA under agreement No. 2022/ABM/06/ 00005-00 for co-financing of a commercial project as part of the Competition for the development of targeted or personalised medicine based on medicinal products based on nucleic acids and small molecule compounds, the Ordering Party is conducting market research on the costs of purchasing and delivering WI-38 and BJ cell lines.
In order to submit an offer, please read the detailed content of the announcement included in request for quotation 95/2025 and send the completed offer form and price and assortment form.
Request for quotation 95/2025 (PDF, 239 KB)